Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment.
Identifieur interne : 000561 ( Main/Exploration ); précédent : 000560; suivant : 000562Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment.
Auteurs : Francis E. Lotrich [États-Unis] ; Anne Germain [États-Unis]Source :
- Acta neuropsychiatrica [ 1601-5215 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Dépression (), Femelle, Humains, Hépatite C chronique (), Hépatite C chronique (psychologie), Hépatite C chronique (traitement médicamenteux), Interféron alpha (effets indésirables), Interféron alpha (usage thérapeutique), Mâle, Ondes du cerveau (), Phases du sommeil (), Polysomnographie, Valeur prédictive des tests, Études prospectives.
- MESH :
- effets indésirables : Interféron alpha.
- psychologie : Hépatite C chronique.
- traitement médicamenteux : Hépatite C chronique.
- usage thérapeutique : Interféron alpha.
- Adulte d'âge moyen, Dépression, Femelle, Humains, Hépatite C chronique, Mâle, Ondes du cerveau, Phases du sommeil, Polysomnographie, Valeur prédictive des tests, Études prospectives.
English descriptors
- KwdEn :
- Brain Waves (drug effects), Depression (chemically induced), Depression (complications), Female, Hepatitis C, Chronic (complications), Hepatitis C, Chronic (drug therapy), Hepatitis C, Chronic (psychology), Humans, Interferon-alpha (adverse effects), Interferon-alpha (therapeutic use), Male, Middle Aged, Polysomnography, Predictive Value of Tests, Prospective Studies, Sleep Stages (drug effects).
- MESH :
- chemical , adverse effects : Interferon-alpha.
- chemically induced : Depression.
- complications : Depression, Hepatitis C, Chronic.
- drug effects : Brain Waves, Sleep Stages.
- drug therapy : Hepatitis C, Chronic.
- psychology : Hepatitis C, Chronic.
- chemical , therapeutic use : Interferon-alpha.
- Female, Humans, Male, Middle Aged, Polysomnography, Predictive Value of Tests, Prospective Studies.
Abstract
Although poor sleep accompanies depression, it is unknown which specific sleep abnormalities precede depression. This is similarly the case for depression developing during interferon-α (IFN-α) therapy. Because vulnerability becomes evident in those who slept poorly before IFN-α, we prospectively determined which specific aspect of sleep could predict subsequent depression.
DOI: 10.1017/neu.2014.30
PubMed: 25434651
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000618
- to stream PubMed, to step Curation: 000618
- to stream PubMed, to step Checkpoint: 000618
- to stream Ncbi, to step Merge: 004017
- to stream Ncbi, to step Curation: 004017
- to stream Ncbi, to step Checkpoint: 004017
- to stream Main, to step Merge: 000561
- to stream Main, to step Curation: 000561
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment.</title><author><name sortKey="Lotrich, Francis E" sort="Lotrich, Francis E" uniqKey="Lotrich F" first="Francis E" last="Lotrich">Francis E. Lotrich</name><affiliation wicri:level="2"><nlm:affiliation>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Germain, Anne" sort="Germain, Anne" uniqKey="Germain A" first="Anne" last="Germain">Anne Germain</name><affiliation wicri:level="2"><nlm:affiliation>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25434651</idno><idno type="pmid">25434651</idno><idno type="doi">10.1017/neu.2014.30</idno><idno type="wicri:Area/PubMed/Corpus">000618</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000618</idno><idno type="wicri:Area/PubMed/Curation">000618</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000618</idno><idno type="wicri:Area/PubMed/Checkpoint">000618</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000618</idno><idno type="wicri:Area/Ncbi/Merge">004017</idno><idno type="wicri:Area/Ncbi/Curation">004017</idno><idno type="wicri:Area/Ncbi/Checkpoint">004017</idno><idno type="wicri:Area/Main/Merge">000561</idno><idno type="wicri:Area/Main/Curation">000561</idno><idno type="wicri:Area/Main/Exploration">000561</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment.</title><author><name sortKey="Lotrich, Francis E" sort="Lotrich, Francis E" uniqKey="Lotrich F" first="Francis E" last="Lotrich">Francis E. Lotrich</name><affiliation wicri:level="2"><nlm:affiliation>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Germain, Anne" sort="Germain, Anne" uniqKey="Germain A" first="Anne" last="Germain">Anne Germain</name><affiliation wicri:level="2"><nlm:affiliation>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA,USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry,Western Psychiatric Institute and Clinics,University of Pittsburgh Medical Center;Pittsburgh,PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></analytic><series><title level="j">Acta neuropsychiatrica</title><idno type="eISSN">1601-5215</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain Waves (drug effects)</term><term>Depression (chemically induced)</term><term>Depression (complications)</term><term>Female</term><term>Hepatitis C, Chronic (complications)</term><term>Hepatitis C, Chronic (drug therapy)</term><term>Hepatitis C, Chronic (psychology)</term><term>Humans</term><term>Interferon-alpha (adverse effects)</term><term>Interferon-alpha (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Polysomnography</term><term>Predictive Value of Tests</term><term>Prospective Studies</term><term>Sleep Stages (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Dépression ()</term><term>Femelle</term><term>Humains</term><term>Hépatite C chronique ()</term><term>Hépatite C chronique (psychologie)</term><term>Hépatite C chronique (traitement médicamenteux)</term><term>Interféron alpha (effets indésirables)</term><term>Interféron alpha (usage thérapeutique)</term><term>Mâle</term><term>Ondes du cerveau ()</term><term>Phases du sommeil ()</term><term>Polysomnographie</term><term>Valeur prédictive des tests</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Interferon-alpha</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Depression</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Depression</term><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain Waves</term><term>Sleep Stages</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Interféron alpha</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Hépatite C chronique</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Interferon-alpha</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hépatite C chronique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Interféron alpha</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Polysomnography</term><term>Predictive Value of Tests</term><term>Prospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Dépression</term><term>Femelle</term><term>Humains</term><term>Hépatite C chronique</term><term>Mâle</term><term>Ondes du cerveau</term><term>Phases du sommeil</term><term>Polysomnographie</term><term>Valeur prédictive des tests</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although poor sleep accompanies depression, it is unknown which specific sleep abnormalities precede depression. This is similarly the case for depression developing during interferon-α (IFN-α) therapy. Because vulnerability becomes evident in those who slept poorly before IFN-α, we prospectively determined which specific aspect of sleep could predict subsequent depression.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Lotrich, Francis E" sort="Lotrich, Francis E" uniqKey="Lotrich F" first="Francis E" last="Lotrich">Francis E. Lotrich</name></region><name sortKey="Germain, Anne" sort="Germain, Anne" uniqKey="Germain A" first="Anne" last="Germain">Anne Germain</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000561 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000561 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25434651
|texte= Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25434651" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |